Providence Capital Advisors, LLC / ABT
Providence Capital Advisors, LLC’s Abbott Laboratories Position
Does Providence Capital Advisors, LLC own Abbott Laboratories (ABT)? Yes — 68.1K shares worth $7M (+1.14% of its 13F portfolio) as of Q1 2026, up from 67.4K shares the prior filed quarter.
Position Value
$7M
Q1 2026
Shares
68.1K
% of Portfolio
+1.14%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 68.1K | $7M | +1.14% |
| Q4 2025 | 67.4K | $8M | +1.42% |
| Q3 2025 | 67.0K | $9M | +1.55% |
| Q2 2025 | 65.5K | $9M | +1.63% |
| Q1 2025 | 64.4K | $9M | +1.78% |
| Q4 2024 | 63.1K | $7M | +1.45% |
| Q3 2024 | 62.7K | $7M | +1.42% |
| Q2 2024 | 61.8K | $6M | +1.40% |
| Q1 2024 | 61.4K | $7M | +1.52% |
| Q4 2023 | 109.9K | $12M | +2.90% |
| Q3 2023 | 112.9K | $11M | +2.86% |
| Q2 2023 | 47.3K | $5M | +1.31% |
| Q1 2023 | 47.1K | $5M | +1.26% |
| Q4 2022 | 48.1K | $5M | +1.43% |
| Q3 2022 | 47.9K | $5M | +1.39% |
| Q2 2022 | 43.2K | $5M | +1.37% |
| Q1 2022 | 44.5K | $5M | +1.29% |
| Q4 2021 | 43.2K | $6M | +1.68% |
| Q3 2021 | 43.2K | $5M | +1.59% |
| Q2 2021 | 41.5K | $5M | +1.55% |
| Q1 2021 | 40.6K | $5M | +1.77% |
| Q4 2020 | 39.4K | $4M | +1.76% |
| Q3 2020 | 28.1K | $3M | +1.61% |
| Q2 2020 | 28.5K | $3M | +1.48% |
| Q1 2020 | 28.6K | $2M | +1.36% |
| Q4 2019 | 25.9K | $2M | +1.21% |
| Q3 2019 | 25.6K | $2M | +1.26% |
| Q2 2019 | 24.7K | $2M | +1.23% |
| Q1 2019 | 24.2K | $2M | +1.22% |
| Q4 2018 | 23.6K | $2M | +1.17% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Providence Capital Advisors, LLC’s full portfolio or all institutional holders of ABT.